CDKAL1-RCAN2 Fusion FISH Probe
The CDKAL1-RCAN2 Fusion FISH Probe is used to confirm a fusion of the CDKAL1 and RCAN2 genes. The fusion of the CDKAL1 and RCAN2 genes has been associated with Bladder Urothelial Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| CDKAL1-RCAN2-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| CDKAL1-RCAN2-20-RERE | 20 (40 μL) | 200 μL |
|
|
| CDKAL1-RCAN2-20-REOR | 20 (40 μL) | 200 μL |
|
|
| CDKAL1-RCAN2-20-REGO | 20 (40 μL) | 200 μL |
|
|
| CDKAL1-RCAN2-20-REGR | 20 (40 μL) | 200 μL |
|
|
| CDKAL1-RCAN2-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| CDKAL1-RCAN2-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| CDKAL1-RCAN2-20-OROR | 20 (40 μL) | 200 μL |
|
|
| CDKAL1-RCAN2-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| CDKAL1-RCAN2-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| CDKAL1-RCAN2-20-GORE | 20 (40 μL) | 200 μL |
|
|
| CDKAL1-RCAN2-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| CDKAL1-RCAN2-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| CDKAL1-RCAN2-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| CDKAL1-RCAN2-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| CDKAL1-RCAN2-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| CDKAL1-RCAN2-20-GROR | 20 (40 μL) | 200 μL |
|
|
| CDKAL1-RCAN2-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| CDKAL1-RCAN2-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| CDKAL1-RCAN2-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| CDKAL1-RCAN2-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| CDKAL1-RCAN2-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| CDKAL1-RCAN2-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| CDKAL1-RCAN2-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| CDKAL1-RCAN2-20-AQAQ | 20 (40 μL) | 200 μL |
|
RCAN2 Gene Summary
This gene encodes a member of the regulator of calcineurin (RCAN) protein family. These proteins play a role in many physiological processes by binding to the catalytic domain of calcineurin A, inhibiting calcineurin-mediated nuclear translocation of the transcription factor NFATC1. Expression of this gene in skin fibroblasts is upregulated by thyroid hormone, and the encoded protein may also play a role in endothelial cell function and angiogenesis. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Oct 2011]
Gene Name: Regulator Of Calcineurin 2
Chromosome: CHR6: 46188468 -46293531
Locus: 6p12.3
CDKAL1 Gene Summary
The protein encoded by this gene is a member of the methylthiotransferase family. The function of this gene is not known. Genome-wide association studies have linked single nucleotide polymorphisms in an intron of this gene with susceptibilty to type 2 diabetes. [provided by RefSeq, May 2010]
Gene Name: CDK5 Regulatory Subunit Associated Protein 1 Like 1
Chromosome: CHR6: 20534687 -21232634
Locus: 6p22.3
Gene Diseases
The CDKAL1 RCAN2 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Bladder Urothelial Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|